The levels of mTOR compared to healthy pulmonary artery smooth muscle cells or endothelial cells without PDGF stimulation are not clear to confirm the basal levels of mTOR in patients with CTEPH vs control cells. The gene discussed is MTOR; the disease is chronic thromboembolic pulmonary hypertension.